U.S. markets close in 1 hour 3 minutes

Company News For Mar 5, 2019

Zacks Equity Research
  • The Children's Place, Inc.’s PLCE shares tanked 10.3% after the company reported fourth quarter 2018 earnings per share of $1.10, lower than the Zacks Consensus Estimate of $2.11 a share
  • Biogen Inc.’s BIIB shares declined 2.1% after the company announced that it had agreed to purchase Nightstar Therapeutics plc NITE for $25.50 a share
  • Shares of Ascendis Pharma A/S ASND rallied 74% after the company announced that its TransCon Growth Hormone trial had achieved the desired primary end result
  • Shares of Takeda Pharmaceutical Company Limited TAK, rose 5.2% after the company announced that it had entered into a partnership with Lupus Therapeutic Partners to start Phase 1 trial for lupus treatment

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ascendis Pharma A/S (ASND) : Free Stock Analysis Report
Biogen Inc. (BIIB) : Free Stock Analysis Report
Children's Place, Inc. (The) (PLCE) : Free Stock Analysis Report
Nightstar Therapeutics PLC Sponsored ADR (NITE) : Free Stock Analysis Report
Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research